In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Eris Lifesciences has informed about the schedule of Analyst/ Institutional Investor Meetings to be held on Wednesday, 27th November, 2019.
The above information is a part of company’s filings submitted to BSE.